Cargando…
ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
The activation of p53 tumor suppressor is essential for preventing abnormal cell proliferation and carcinogenesis. ZCCHC10 was previously identified as a potential p53-interacting partner in a yeast two-hybrid screen, but the interaction in cells and its subsequent influence on p53 activity and canc...
Autores principales: | Ning, Yichong, Hui, Na, Qing, Bei, Zhuo, Yiming, Sun, Wei, Du, Yan, Liu, Shunlian, Liu, Kaili, Zhou, Jianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538723/ https://www.ncbi.nlm.nih.gov/pubmed/31138778 http://dx.doi.org/10.1038/s41419-019-1635-9 |
Ejemplares similares
-
CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression
por: Ning, Yichong, et al.
Publicado: (2019) -
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia
por: Zhou, Hao, et al.
Publicado: (2023) -
Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2
por: Sparks, Alison, et al.
Publicado: (2022) -
NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
por: Liu, Xiaofeng, et al.
Publicado: (2016) -
Selective microRNA uridylation by Zcchc6 (TUT7) and Zcchc11 (TUT4)
por: Thornton, James E., et al.
Publicado: (2014)